Neogap secures SEK 87 million for personalized cancer immunotherapy
“Neogap is at a stage where clear progress is combined with strong potential in an area of significant medical need”
Advertisement
The ongoing clinical study is a first-in-human trial evaluating Neogap’s personalised cell therapy in patients with advanced colorectal cancer. The primary focus is on safety and tolerability, while the study also generates early clinical and exploratory data. Several patients have been treated, and previously communicated safety data indicate that the treatment is well tolerated.
Neogap secures SEK 87 million to advance clinical development of its personalised immunotherapy
Neogap Therapeutics AB
In parallel, Neogap has received approval from the Swedish Medical Products Agency to treat all patients in the study at full dose. This enables a more flexible and efficient study design. As part of its EIC grant, Neogap has, in collaboration with CDMO NorthX Biologics, developed a manufacturing framework to support later-stage clinical trials and future commercialisation.
“The capital enables us to continue advancing the ongoing clinical study and to take the next step in our development programme. Over the past year, we have reached several important milestones, including treating patients, generating initial safety data and receiving regulatory approvals. We are also seeing encouraging signals in our exploratory data. We now look forward to intensifying preparations for the next stage of clinical development,” says Samuel Svensson, CEO of Neogap Therapeutics.
“Neogap is at a stage where clear progress is combined with strong potential in an area of significant medical need,” says Andreas Lindblom, Managing Partner at Sciety. “The company has a unique therapeutic approach to T-cell therapy, combining personalised treatment with a scalable manufacturing process, which was an important factor behind our engagement in the financing.”
Other news from the department business & finance
Most read news
More news from our other portals
Something is happening in the life science industry ...
This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.